Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

NCT04319237 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.

NCT NCT04319237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04319237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Phase
Observational
Overall status
Completed
Start date
March 10, 2020
Completion date
July 31, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma, transformed lymphoma